SIGN IN / REGISTER
(1) -
$
5.94
Menu
Home
Products
Providers
Education
Forms
Contact Us
Toggle Dropdown
by Item #
by Manufacturer #
by Brand
Home
/
Vaccines / Refrig Pharma
/ Corticosteroid Budesonide 0.5 mg / 2 mL Inhalation Suspension Ampule 2 mL
View cart
“Antimuscarinic / Antispasmodic Ipratropium Bromide 0.02%, 0.2 mg / mL Unit Dose, Inhalation Solution Vial 25 Vials” has been added to your cart.
Corticosteroid Budesonide 0.5 mg / 2 mL Inhalation Suspension Ampule 2 mL
UOM CARTON/1
$
333.40
Features
30 nebulizer ampules
10000 in stock
Corticosteroid Budesonide 0.5 mg / 2 mL Inhalation Suspension Ampule 2 mL quantity
Add to cart
Category:
Vaccines / Refrig Pharma
Description
Description
Item ID #
14518900
Manufacturer #
1451343
Brand
Features
30 nebulizer ampules
Related products
#12458900 Mfr# 1245695
Inhalation Solution 2.25% Strength Solution 30 per Box
Features
For use in a hand-held rubber bulb nebulizer
Great for treatment of croup, RSV, bronchitis and smoke inhalation
Sterile unit dose
UOM CARTON/30
$54.924
Add to cart
#47718900 Mfr#
Beta-Adrenergic Agonist Albuterol Sulfate 0.083%, 2.5 mg / 3 mL Unit Dose, Inhalation Solution Nebulizer Vial 30 Vials
Item ID # 47718900 Manufacturer # 2434801 Brand
UOM CARTON/30
$7.62
Add to cart
#58908900 Mfr#
Menactra® Meningitis Vaccine Meningococcal (Groups A,C,Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Preservative Free 4 mcg / 0.5 mL Injection Single Dose Vial 0.5 mL
Features
Menactra is indicated for active immunization of individuals 2 through 55 years of age for the prevention of invasive meningococcal disease
Menactra vaccine is administered as a 0.5 mL dose by intramuscular injection
In children 9 through 23 months of age, Menactra is given as a 2-dose series three months apart
UOM CASE/5
$869.472
Add to cart
#58908900 Mfr# 589-05
Menactra® Meningitis Vaccine Meningococcal (Groups A,C,Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Preservative Free 4 mcg / 0.5 mL Injection Single Dose Vial 0.5 mL
Features
Menactra is indicated for active immunization of individuals 2 through 55 years of age for the prevention of invasive meningococcal disease
Menactra vaccine is administered as a 0.5 mL dose by intramuscular injection
In children 9 through 23 months of age, Menactra is given as a 2-dose series three months apart
UOM CASE/5
$869.472
Add to cart